Switch to
More onapp

Suven Pharmaceuticals Ltd

SUVENPHAR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹11,675 cr, stock is ranked 319
Moderate RiskStock is 2.02x as volatile as Nifty
460.451.80 (+0.39%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹11,675 cr, stock is ranked 319
Moderate RiskStock is 2.02x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
25.73
PB RatioPB Ratio
7.65
Dividend YieldDiv. Yield
1.09%
Sector PESector PE
35.92
Sector PBSector PB
4.36
Sector Div YldSctr Div Yld
0.88%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Suven Pharmaceuticals Limited is an India-based company that is primarily engaged in providing services to global life science and fine chemical, including custom synthesis, process research and development, scale up and contract manufacturing of intermediates, active pharmaceutical ingredients (APIs) and formulations. The Company operates through Pharmaceuticals Manufacturing and Services segment. Its geographical segments include India, the United States, Europe and Rest of the World. In India, the Company sells bulk drugs and intermediates, fine chemicals and services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In Rest of the World, the Company sells bulk drugs, intermediates and services. The Company’s wholly owned subsidiary is Suven Pharma Inc.

Investor PresentationView older 

Aug 8, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

20192020202120220.380.901.081.450.110.320.360.45
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 1.96%

See detailed holdings

Recent EventsAll events 

Related Party Transaction 
Announced OnNov 21, 2022

Suven Pharmaceuticals Limited has informed the Exchange about related party transaction for the period ended September 2022 | Download

Suven Pharmaceuticals Limited has informed the Exchange about related party transaction for the period ended September 2022 | Download

Transcript of Analysts/Institutional Investor Meet/Con. Call 
Announced OnNov 15, 2022

Suven Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

Suven Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

Cash Dividend 
Ex. DateSep 9, 2022

Interim • Div/Share: ₹ 1

See all events